
Shin Hon Chen
Examiner (ID: 706, Phone: (571)272-3789 , Office: P/2431 )
| Most Active Art Unit | 2431 |
| Art Unit(s) | 2131, 2431 |
| Total Applications | 1314 |
| Issued Applications | 1098 |
| Pending Applications | 88 |
| Abandoned Applications | 152 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17625663
[patent_doc_number] => 20220160678
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => MODULATION OF MOLECULAR MARKERS USING S-EQUOL
[patent_app_type] => utility
[patent_app_number] => 17/535125
[patent_app_country] => US
[patent_app_date] => 2021-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19069
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -45
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17535125
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/535125 | Modulation of molecular markers using S-equol | Nov 23, 2021 | Issued |
Array
(
[id] => 18841669
[patent_doc_number] => 20230404072
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => BIOCIDE
[patent_app_type] => utility
[patent_app_number] => 18/038090
[patent_app_country] => US
[patent_app_date] => 2021-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25775
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18038090
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/038090 | BIOCIDE | Nov 22, 2021 | Pending |
Array
(
[id] => 18921335
[patent_doc_number] => 20240024339
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-25
[patent_title] => COMPOSITION CONTAINING WATER-SOLUBLE DRUG CAUSING VASCULAR DISORDER, SOLUTION FOR USE IN PREPARATION OF ADMINISTRATION SOLUTION CONTAINING WATER-SOLUBLE DRUG CAUSING VASCULAR DISORDER, KIT, AGENT FOR SUPPRESSING VASCULAR DISORDER, AND SOLUTION CONTAINING NONIONIC SURFACTANT
[patent_app_type] => utility
[patent_app_number] => 18/036981
[patent_app_country] => US
[patent_app_date] => 2021-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14042
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18036981
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/036981 | COMPOSITION CONTAINING WATER-SOLUBLE DRUG CAUSING VASCULAR DISORDER, SOLUTION FOR USE IN PREPARATION OF ADMINISTRATION SOLUTION CONTAINING WATER-SOLUBLE DRUG CAUSING VASCULAR DISORDER, KIT, AGENT FOR SUPPRESSING VASCULAR DISORDER, AND SOLUTION CONTAINING NONIONIC SURFACTANT | Nov 17, 2021 | Pending |
Array
(
[id] => 18842511
[patent_doc_number] => 20230404915
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => RAPIDLY DISINTERGRATING COMPOSTIONS AND METHODS (Nicotine)
[patent_app_type] => utility
[patent_app_number] => 18/252688
[patent_app_country] => US
[patent_app_date] => 2021-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14601
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18252688
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/252688 | RAPIDLY DISINTERGRATING COMPOSTIONS AND METHODS (Nicotine) | Nov 11, 2021 | Pending |
Array
(
[id] => 18893645
[patent_doc_number] => 20240009130
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-11
[patent_title] => RAPIDLY INFUSING COMPOSITIONS FOR ORAL MUCOSAL DELIVERY AND METHODS
[patent_app_type] => utility
[patent_app_number] => 18/252676
[patent_app_country] => US
[patent_app_date] => 2021-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15168
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18252676
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/252676 | RAPIDLY INFUSING COMPOSITIONS FOR ORAL MUCOSAL DELIVERY AND METHODS | Nov 11, 2021 | Pending |
Array
(
[id] => 18829610
[patent_doc_number] => 20230398134
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-14
[patent_title] => SOLID DISPERSIONS OF CANNABIDIOL
[patent_app_type] => utility
[patent_app_number] => 18/252067
[patent_app_country] => US
[patent_app_date] => 2021-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5071
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18252067
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/252067 | SOLID DISPERSIONS OF CANNABIDIOL | Nov 11, 2021 | Pending |
Array
(
[id] => 18350914
[patent_doc_number] => 20230139025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => ANTIOXIDANT FOR USE IN TREATMENT FOR RIBE
[patent_app_type] => utility
[patent_app_number] => 17/518590
[patent_app_country] => US
[patent_app_date] => 2021-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4220
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17518590
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/518590 | ANTIOXIDANT FOR USE IN TREATMENT FOR RIBE | Nov 3, 2021 | Abandoned |
Array
(
[id] => 18893634
[patent_doc_number] => 20240009119
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-11
[patent_title] => RAPIDLY INFUSING COMPOSITIONS WITH SUPPLEMENTS AND TREATMENT METHODS
[patent_app_type] => utility
[patent_app_number] => 18/252681
[patent_app_country] => US
[patent_app_date] => 2021-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15365
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -49
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18252681
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/252681 | RAPIDLY INFUSING COMPOSITIONS WITH SUPPLEMENTS AND TREATMENT METHODS | Nov 3, 2021 | Pending |
Array
(
[id] => 17593619
[patent_doc_number] => 20220143192
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => COMPOSITIONS COMPRISING VITAMINS/MINERALS IN A POLYPHENOLIC MATRIX, METHODS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/517197
[patent_app_country] => US
[patent_app_date] => 2021-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4582
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17517197
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/517197 | Compositions comprising vitamins/minerals in a polyphenolic matrix, methods and uses thereof | Nov 1, 2021 | Issued |
Array
(
[id] => 17576902
[patent_doc_number] => 20220133757
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => AQUEOUS COMPOSITIONS OF BORTEZOMIB
[patent_app_type] => utility
[patent_app_number] => 17/516400
[patent_app_country] => US
[patent_app_date] => 2021-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23833
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17516400
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/516400 | Aqueous compositions of bortezomib | Oct 31, 2021 | Issued |
Array
(
[id] => 19096349
[patent_doc_number] => 20240115576
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => Caffeine Compositions
[patent_app_type] => utility
[patent_app_number] => 18/034142
[patent_app_country] => US
[patent_app_date] => 2021-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10616
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 1
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18034142
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/034142 | Caffeine Compositions | Oct 28, 2021 | Pending |
Array
(
[id] => 19601060
[patent_doc_number] => 20240391940
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-28
[patent_title] => FUSED RING-CONTAINING COMPOUND, APPLICATION THEREOF, AND COMPOSITION CONTAINING SAME
[patent_app_type] => utility
[patent_app_number] => 18/033292
[patent_app_country] => US
[patent_app_date] => 2021-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33173
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 179
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18033292
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/033292 | FUSED RING-CONTAINING COMPOUND, APPLICATION THEREOF, AND COMPOSITION CONTAINING SAME | Oct 21, 2021 | Pending |
Array
(
[id] => 17532344
[patent_doc_number] => 20220110953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING HUMAN PAPILLOMAVIRUS (HPV)-INDUCED CANCERS
[patent_app_type] => utility
[patent_app_number] => 17/501667
[patent_app_country] => US
[patent_app_date] => 2021-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9303
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17501667
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/501667 | METHODS AND COMPOSITIONS FOR TREATING HUMAN PAPILLOMAVIRUS (HPV)-INDUCED CANCERS | Oct 13, 2021 | Abandoned |
Array
(
[id] => 19151161
[patent_doc_number] => 11976057
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-07
[patent_title] => MrgX2 antagonists
[patent_app_type] => utility
[patent_app_number] => 17/492978
[patent_app_country] => US
[patent_app_date] => 2021-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 112790
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 491
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17492978
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/492978 | MrgX2 antagonists | Oct 3, 2021 | Issued |
Array
(
[id] => 18953494
[patent_doc_number] => 20240041821
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => 1,8-CINEOLE CONTAINING COMPOSITION FOR THERAPEUTIC USE
[patent_app_type] => utility
[patent_app_number] => 18/258455
[patent_app_country] => US
[patent_app_date] => 2021-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17641
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18258455
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/258455 | 1,8-CINEOLE CONTAINING COMPOSITION FOR THERAPEUTIC USE | Sep 30, 2021 | Pending |
Array
(
[id] => 18786016
[patent_doc_number] => 20230373942
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-23
[patent_title] => Process for the Production of Cannabinol, Cannabinolic Acid, Cannabivarin, Cannabivarinic Acid and Related Cannabinoids
[patent_app_type] => utility
[patent_app_number] => 18/247573
[patent_app_country] => US
[patent_app_date] => 2021-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7744
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18247573
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/247573 | Process for the Production of Cannabinol, Cannabinolic Acid, Cannabivarin, Cannabivarinic Acid and Related Cannabinoids | Sep 29, 2021 | Pending |
Array
(
[id] => 17503310
[patent_doc_number] => 20220096412
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => Combination Drug Substance of Polyamine Transport Inhibitor and DFMO
[patent_app_type] => utility
[patent_app_number] => 17/490492
[patent_app_country] => US
[patent_app_date] => 2021-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17698
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17490492
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/490492 | Combination drug substance of polyamine transport inhibitor and DFMO | Sep 29, 2021 | Issued |
Array
(
[id] => 19058988
[patent_doc_number] => 11938182
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-26
[patent_title] => Halogenated xanthenes as vaccine adjuvants
[patent_app_type] => utility
[patent_app_number] => 17/488430
[patent_app_country] => US
[patent_app_date] => 2021-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 22
[patent_no_of_words] => 12471
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17488430
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/488430 | Halogenated xanthenes as vaccine adjuvants | Sep 28, 2021 | Issued |
Array
(
[id] => 18287011
[patent_doc_number] => 20230102483
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => [6R]-MTHF IN 5-FU BASED CHEMOTHERAPY OF LEFT-SIDED COLORECTAL CANCER
[patent_app_type] => utility
[patent_app_number] => 17/488120
[patent_app_country] => US
[patent_app_date] => 2021-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13908
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17488120
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/488120 | [6R]-MTHF IN 5-FU BASED CHEMOTHERAPY OF LEFT-SIDED COLORECTAL CANCER | Sep 27, 2021 | Pending |
Array
(
[id] => 17356719
[patent_doc_number] => 20220017515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => sGC STIMULATORS
[patent_app_type] => utility
[patent_app_number] => 17/485858
[patent_app_country] => US
[patent_app_date] => 2021-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54739
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17485858
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/485858 | sGC stimulators | Sep 26, 2021 | Issued |